Search Results 401-410 of 17281 for hba1c
Participants in Part 1 will receive either pembrolizumab or placebo in a double-blind design for up to 17 cycles. ... The primary hypothesis of this study is that ...
Learn the symptoms and treatment of this condition — which raises the risk of heart attack and stroke — and the lifestyle changes that can lower the risk.
The purpose of this international study is to evaluate the effect of dapagliflozin 10 mg versus placebo in HFpEF patients, given once daily in addition to ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
Subject has uncontrolled diabetes as evidenced by an HbA1c > 7% prior to surgery. Subject has a known allergy to FD&C Blue #1 and/or FD&C Yellow #5 or any ...
About this study. To determine if the addition of midostaurin (PKC412) to Standard of Care (SOC) therapy reduces relapse in FLT3-ITD mutated AML patients ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to establish incidence and prevalence of Impulse Control Disorders (ICDs) in patients with prolactinomas treated with dopamine ...
Mayo Clinic's Biliary Epigenetics and Regenerative Medicine Lab led by Robert C. Huebert, M.D., provides training, education and career opportunities to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.